Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Dose adjustments, side effect management, and lab follow-up are the norm
Dulaglutide and lixisenatide showed relatively lower overall GI tolerability burden
Diabetes Res Clin Pract 2018;143:378-88.ArticlePubMed 6
Krehl, L.J
Gastrointestinal symptoms such as nausea and transient vomiting are expected during titration, so monitoring dose timing, meal composition, and hydration during the first 3 months helps distinguish a therapeutic gut response from intolerable side effects
US$ 28.26
US$ 22.26
US$ 24.75
US$ 21.33
US$ 21.45
